Ratings by Ladenburg Thalmann (Matt Kaplan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/18/2024 | Eyenovia | EYEN | Downgrade | Neutral (Buy) |
0.10 (15.82) |
15720% | Details | |
| 1/3/2023 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Renovacor, Inc. | RCOR | Downgrade | Neutral (Buy) |
1.90 (3.20) |
68.42% | Details | |
| 8/4/2022 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2022 | Allena Pharmaceuticals | ALNA | Downgrade | Neutral (Buy) |
0.48 (0.08) |
-83.33% | Details | |
| 8/11/2021 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2020 | Cogent | COGT | New Coverage | Buy (N/A) |
2.89 (37.08) |
1183.04% | Details | |
| 5/14/2020 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2020 | Allena Pharmaceuticals | ALNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2019 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details |
